Research Article

Rise of CC398 Lineage of Staphylococcus aureus among Infective Endocarditis Isolates Revealed by Two Consecutive Population-Based Studies in France

  • Anne Tristan mail,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • Jean-Philippe Rasigade,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • Esmée Ruizendaal,

    Affiliation: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France

  • Frédéric Laurent,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • Michèle Bes,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • Hélène Meugnier,

    Affiliation: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France

  • Gérard Lina,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • Jerome Etienne,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • Marie Celard,

    Affiliation: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France

  • Pierre Tattevin,

    Affiliation: Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France

  • Stefan Monecke,

    Affiliation: Institute for Medical Microbiology and Hygiene, Faculty of Medicine “Carl Gustav Carus”, Technical University of Dresden, Dresden, Germany

  • Vincent Le Moing,

    Affiliation: Département des maladies infectieuses et tropicales, hôpital Gui-de-Chauliac, Montpellier, France

  • François Vandenesch,

    Affiliations: Hospices Civils de Lyon, Centre National de Référence des Staphylocoques, Bron, France, Université de Lyon, Domaine de la Buire, Lyon, France, INSERM U851, Bacterial Pathogenesis and Innate Immunity Laboratory, Lyon, France

  • the French AEPEI study Group on Infective Endocarditis
  • Published: December 13, 2012
  • DOI: 10.1371/journal.pone.0051172


Staphylococcus aureus isolates from two prospective studies on infective endocarditis (IE) conducted in 1999 and 2008 and isolated from non-IE bacteremia collected in 2006 were spa-typed and their virulence factors were analyzed with a microarray. Both populations were genetically diverse, with no virulence factors or genotypes significantly more associated with the IE isolates compared with the non-IE isolates. The population structure of the IE isolates did not change much between 1999 and 2008, with the exception of the appearance of CC398 methicillin-susceptible Staphylococcus aureus (MSSA) isolates responsible for 5.6% of all cases in 2008. In 1999, this lineage was responsible for no cases. The increasing prevalence of S. aureus in IE is apparently not the result of a major change in staphylococcal population structure over time, with the exception of the emerging CC398 MSSA lineage.


Infective endocarditis (IE) is a rare but severe disease, which characteristics have changed over the past decades, and a shift in causative microorganisms has been observed. Staphylococci have surpassed streptococci as the primary group of IE-causing pathogens [1], as confirmed by a number of observational studies [2], [3]. Our study group conducted three population-based studies of IE in 1991, 1999 and 2008, using the same methods, based on a quarter of the French population [4][6]. These studies revealed an increasing S. aureus prevalence over the two decades covered by those three individual year time points (16.1%, 21.1%, and 25.7% for 1991, 1999 and 2008, respectively) [4]. In the 2008 survey, although the streptococci as a group were more frequently observed, S. aureus was the leading single-species cause of IE. Moreover, healthcare-associated IE accounted for almost 25% of all IE cases [6]. This result is consistent with other studies that previously indicated a shift from IE, mostly of dental origin, to a predominance of healthcare-related infections [7]. These evolutions in the microbial epidemiology of IE have been attributed to population aging, changes in predisposing cardiac conditions, and bloodstream infection (BSI) patterns [8]. However, no study has examined whether a qualitative change of the microorganisms responsible for IE, such as a shift in the causative lineages or the emergence of new clones of S. aureus, has occurred over time.

Another important question concerns the specificity of infective endocarditis strains with respect to other S. aureus infections. When comparing methicillin-susceptible S. aureus (MSSA) from uncomplicated infections (uncomplicated bacteremia and soft tissue infections) with those isolated from IE or haematogenous bone and joint infections within the same hospital, Fowler et al found that CC5 and CC9 were associated with an increased severity of infection [9]. In another study comparing geographically matched complicated skin- and soft-tissue infection (SSTI) MSSA isolates with IE MSSA isolates, Nienaber et al found that CC30 was the sole genotype that was significantly more frequent in IE than in SSTI isolates [10]. However, the question remains as to whether S. aureus IE isolates differ from non-IE bacteremia isolates. Finally, one striking observation by Nienaber et al [10] is that the genes encoding toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxin A (SEA), two major superantigens from S. aureus, were extremely prevalent in IE isolates from the United States (93.9% and 64.9% respectively). These results suggest that IE isolates harbor specific virulence factors that differ from those found in isolates sampled from people suffering other diseases.

In the present paper, we thoroughly analyzed a collection of S. aureus IE isolates collected in 2008 during a population-based survey that covered a quarter of French territory. To assess the temporal changes associated with IE-causing staphylococci, we compared the population structure of these isolates with those from a similar survey conducted in 1999. To determine the specificity of IE isolates versus non-IE bacteremia isolates we compared the population structure and the virulence gene content of IE isolates from the 2008 survey with those from non-IE bacteremia isolates collected throughout France in 2006–2007.


Genotyping of IE MSSA isolates

The genotypes of the 89 MSSA IE isolates were analyzed both by spa typing and by the use of a microarray. The microarray assigned all isolates to clonal complexes (CCs). Overall, there was a large genotypic diversity as exemplified by the 18 different CCs detected. However, four CCs (CC45, CC5, CC15 and CC30) accounted for >50% of the 89 isolates (Table 1). Among the less frequent CCs, five isolates (5.6%) belonged to CC398. This assignment was verified by a CC398-specific PCR [11]. The genetic diversity of the IE isolates was further confirmed by spa-typing indicating that the 89 isolates were distributed among 63 spa types and 11 spa clusters, with 5 spa clusters accounting for >50% of the isolates.


Table 1. A comparison of the population structures of methicillin-susceptible Staphylococcus aureus isolates from patients with infective endocarditis (IE) or bloodstream infection (BSI) without IEa.


To determine whether the population structure of the IE isolates was stable over time, the spa types of the S. aureus isolates collected during the 1999 French IE survey were determined. The results indicated that the two groups of isolates were genotypically very comparable with the spa types of the 2008 isolates interspaced with those of 1999 isolates (Figure 1). The exception was CC398, as none of the spa cluster identified in 1999 could be assigned to CC398.


Figure 1. Phylogenetic tree based on spa type of S. aureus IE isolates from 1999 and 2008 surveys.

Figure 1. Circular representation of the phylogenetic tree obtained using UPGMA method ( The spa types were clustered into CCs (ie, spaCCs) by use of the integrated BURP (Based Upon Repeat Patterns) algorithm. User-definable parameters were set as follows: “cluster spa types into spaCC if cost distances are less than or equal to 4” and “exclude spa types shorter than 5 repeats.” This parameter combination ensures optimal concordance (95.3%) between BURP and e- BURST ( Only major spaCC are represented.


Correlation between CC and disease parameters

In order to determine whether certain lineages of S. aureus could be associated with certain clinical characteristics of the patients, search of associations between CC (assigned by the microarrays) and the patient database of the 2008 survey [6] was performed. The only significant association detected was between intravenous drug addiction and CC8. Four of the 8 CC8 isolates (50.0%) versus 14 of the 81 non-CC8 isolates (17.3%) were associated with IV drug abuse (P<0.05, two-tailed Fisher's exact test).

Comparison of IE to non-IE blood-culture MSSA isolates

To assess whether IE isolates correspond to peculiar lineages and harbor specific virulence factors in comparison to non-IE isolates, the population structure of the 89 MSSA IE isolates of the 2008 survey was compared with that of the 81 blood culture non-IE isolates collected in France during 2006. Genotypic comparison, as assessed both by spa typing and microarrays, revealed that the two populations were genotypically superimposable in regard to CCs (inferred from microarrays) (Table 1) and spa clusters (Figure 2). Figure 2 depicts that each spa cluster contained both IE and non-IE isolates. The two isolate populations were then compared to determine the prevalence of individual virulence factor genes. Genomic DNA microarray analysis comparison of the 89 MSSA IE isolates with the 81 non-IE bacteremia isolates indicated that there were no specific genes (including virulence factor genes) that could be significantly assigned to IE versus bacteremia isolates (Table 2 and Table S1). The known adhesin genes present in at least 60% of isolates of both groups were fnbAB (fibronectin binding protein A–B), clfAB (clumping factor A–B), spa (protein A), sdrCD (ser-asp rich fibrinogen-binding, bone sialoprotein-binding protein C and D), bbp (bone sialoprotein-binding protein), ebpS (cell wall associated fibronectin-binding protein) and map (major histocompatibility complex class II analog protein). Similarly, the exotoxins and other putative virulence factors present in at least 60% of isolates in both groups were seg/sei (encoding the egc cluster), icaA (intercellular adhesion protein) and chp (chemotaxis inhibitory protein) (Table 2).


Figure 2. Phylogenetic tree based on spa type of S. aureus IE isolates (2008 survey) and bloodstream infections without IE (2006 survey).

See Figure 1 legend for details.


Table 2. A comparison of the genotypic profiles of methicillin-susceptible Staphylococcus aureus isolates from patients with infective endocarditis (IE) or bloodstream infection (BSI) without IEa.



A wide range of different S. aureus clonal complexes were found to be involved in IE. Altogether, 18 different CCs were detected. This distribution did not vary much over time as assessed by the spa-typing comparison of the 1999 and 2008 isolates (Figure 1). This observation suggests that the increased prevalence of S. aureus accompanying endocarditis is not due to a change in bacterial population structure but rather mainly due to non-bacterial factors, including population aging and an increase in conditions favoring S. aureus endocarditis, such as the use of prosthetic valves, pace-makers and hospitalization [6]. An exception to the general stability of the S. aureus population structure over time is the identification of five CC398 strains in the 2008 survey. CC398 includes MSSA and methicillin-resistant S. aureus (MRSA), the latter being associated with livestock-associated infections, mainly in pigs [12], although cases of infections in humans with this lineage have been described [13]. Only limited documentation of CC398 MSSA strains exists [14]. However, with a frequency of 5 out of 89 isolates (5.6%), CC398 MSSA cannot be neglected as an important IE pathogen in humans. Other reports suggest that CC398 is a new emerging pathogenic lineage in humans [13], [15][17]. Future studies are needed to determine whether this lineage will continue to expand throughout the population.

When comparing IE versus non-IE isolates from the same geographic area, we found no difference in the population structure between the IE and non-IE bacteremia isolates. CC5 and CC45 dominate in both populations and CC398 was equally prevalent in IE and non-IE isolates (Table 1). This result is consistent with other studies, which also found highly heterogenic strains in S. aureus infection without any particular CC dominating involvement in invasive infections [18]. Of note, CC30 was slightly less represented in the two populations (13.6% in IE, 12.4% in non-IE infection) than it was in the Nienaber study (19.5% in IE) [10].

The population structure of our IE and non-IE isolates does not appear to be different from that observed with other invasive or colonizing isolate series. For instance, the population structure of MSSA from 943 invasive infections in the Netherland over a period of 11 years revealed that a majority of isolates belonged to the same CCs as our series [18]. Interestingly, nasal carriage isolates from a collection of 155 carriers (152 MSSA and 3 MRSA) sampled in Germany belonged, in a decreasing order of prevalence, to CC8, CC30, CC15 and CC45, which correspond to four of the five most prevalent CCs in our series [19]. Likewise, when comparing CC affiliations of IE isolates to S. aureus isolate typing data obtained from healthy carriers or bone infections in Germany [19], [20], a similar pattern can be observed. In line with the lack of correlation between CC and diseases vs carriage, we found no major association between CC and clinical characteristics of the infective endocarditis with the exception of CC8 with IV drug abuse. Although significant, this association relies on a small population. In the context of IV drug abuse, this association may reflect a propensity of the CC8 lineage to better colonize the skin.

When considering the virulence factors potentially associated with IE, a number of staphylococcal adhesins are considered to play a role in the pathogenesis of infective endocarditis, both in vitro or when using animal experimental models. This list includes clumping factor A–B [21], [22], fibronectin-binding protein A–B [21], collagen-binding protein [23], SdrD/E [22] and polysaccharide intercellular adhesin [24]. In our series of IE isolates, these factors, with the exception of collagen-binding protein gene (cna), were highly prevalent; however, they were equally prevalent in non-IE bacteremia isolates (Table 2), suggesting that they might be required but are not sufficient for the development of IE. All other variable virulence genes were equally prevalent in the two populations (Table S1). Altogether, it appears that the population structure and prevalence of variable virulence genes are not significantly different between invasive isolates responsible for bloodstream infections. These observations do not rule out the possibility of differential expression of virulence factors between isolates as suggested by some studies [25].

As mentioned in the introduction, TSST-1 and SEA-encoding gene were extremely prevalent in IE isolates from the United States (93.9% and 64.9% respectively) [10]. These results are quite different from our epidemiology for both our IE isolates (9% tst and 18% sea) and non-IE bacteremia isolates (19.8% tst and 21% sea), as well as different from the collection of nasal carriage studied by Monecke et al with the same arrays (14.84% tst and 17.42% sea) [19]. As mentioned by Nienaber, the high prevalence of major superantigens in their series could “reflect linkage disequilibrium with unidentified virulence genes and represent a ‘biomarker’ of S. aureus isolates with an increased risk for IE rather than a causal association” [10]. Whole-genome sequencing of these isolates is currently under way (V. Fowler, personal communication) and may address this important issue. Finally, Panton-Valentine leukocidin (PVL) was not detected in any IE or bloodstream infection isolates from our series and was detected at a frequency below 20% in the US series [10].

There is one limitation to the present study. The strains collected from the non-IE patients were retrieved from a survey in which IE was not formerly ruled out by performing a trans-esophageal echocardiography (TEE) [26]. Thus, a few cases of IE may have been misdiagnosed in the present non-IE bacteremia series. However, given the expected prevalence of IE within the bacteremia isolates from various studies (5–10% in healthcare-related, 10 to 15% in community-acquired S. aureus bacteremia) [27], [28], this bias is unlikely to have had a significant impact on our observation that IE and non-IE isolates carry similar genetic backgrounds and virulence profile genes. However, a current prospective study matching IE and non-IE cases, both ascertained by the performance of a TEE, will provide a definite answer to this important question.

In conclusion, our data reveal that there was a wide genetic diversity within MSSA strains, with no virulence factors or CC particularly more involved in IE as compared to non-IE bacteremia, suggesting that the occurrence of infective endocarditis during S. aureus bacteremia depends essentially on host factors. The population structure of IE isolates changed little between the two surveys performed 9 years apart with the exception of an emerging phenomenon, the rise of the CC398 MSSA lineage as a cause of invasive infections.

Materials and Methods

Bacterial strains

IE Isolates.

A collection of 89 MSSA, and 39 MSSA IE non-duplicate isolates collected during respective 2008 [6] and 1999 [5] population-based surveys was included in the study. These isolates were from confirmed cases of MSSA IE as determined by the modified Duke criteria [29]. Both one-year surveys (1999 and 2008) were conducted using the same methods. However, the 2008 study covered a larger area of French territory than the 1999 survey. Hence, when comparing the isolates of the two studies, the 2008 collection was restricted to the 78 MSSA isolates collected in the same area as the 1999 survey.

Non-IE isolates.

Eighty-one blood culture isolates out of 116 invasive infection isolates (all MSSA) collected during a prospective multicenter study from September 2006 to February 2007 by 23 representative French hospital laboratories were included [26].

Genotyping methods

Bacterial DNA was extracted according to the manufacturer's recommended protocol using commercial extraction kits (Qiagen). The diagnostic DNA microarrays, Identibac S. aureus Genotyping ® (Alere) used for this study, as well as related procedures and protocols, have been previously described in detail [19]. This microarray covers 332 different target sequences corresponding to approximately 185 distinct genes and their allelic variants. The assignation of isolates to clonal complexes (CCs) was determined by the comparison of hybridization profiles to previously typed multilocus sequence typing (MLST) reference strains [19].

A DNA sequence-based analysis of the protein A gene variable region was performed as previously described [30] using the nomenclature as described on the Ridom website ( To infer clonal relatedness, the Based Upon Repeat Pattern (BURP) algorithm was used followed by circular representation of the phylogenetic tree obtained using UPGMA method ( [31].

Clinical characteristics of patient

The patient information of the 2008 survey had been collected prospectively by use of a standardized case report form as described [6]. The following variable were collected: sex, date of birth, living place, date of first symptoms and of first hospitalization, transfer from/to another facility, history of heart disease, comorbidities, Charlson index, procedures and situations at risk for IE, signs and symptoms of IE, echocardiographic data, microbiological data, laboratory and imaging investigations, medical and surgical treatment, and outcome [6].

Statistical analysis

Differences in the distributions of genes, alleles, genotypes and clinical features were tested for significance using a two-tailed Fisher's exact test. Contingency tables larger than 2×2 used in population structure comparisons were first analyzed as a whole, then each proportion was individually tested for significance. To reflect the exploratory nature of the analysis, P-values were not corrected for multiple testing. P-values of <0.05 were considered to be statistically significant. Statistical analyses were performed using R software version 2.14.2 (The R Foundation for Statistical Computing, Vienna, Austria).

Supporting Information

Table S1.

A comparison of the distributions of genes or alleles in methicillin-susceptible Staphylococcus aureus isolates from patients with infective endocarditis (IE) or bloodstream infection (BSI) without IE (only genes not shown in Table1 are presented).




We are fully indebted to the physicians and microbiologists who participated in these surveys. We wish also to thank Christine Gardon, Christine Courtier, Caroline Bouveyron and Virginie Dumoulin for excellent technical assistance.

AEPEI Study Group on Infective Endocarditis

Principal investigators: B. Hoen, X. Duval; Other members: F. Alla, A. Bouvet, S. Briançon, N. Danchin, F. Delahaye, X. Duval, J. Etienne, V. Le Moing, C. Leport, C. Selton-Suty, and F. Vandenesch

Author Contributions

Conceived and designed the experiments: AT FL MB PT VLM FV. Performed the experiments: AT MB HM SM. Analyzed the data: AT ER JPR FL MB GL JE MC. Contributed reagents/materials/analysis tools: SM. Wrote the paper: AT ER JPR MB PT VLM FV.


  1. 1. Moreillon P, Que YA (2004) Infective endocarditis. Lancet 363: 139–149. doi: 10.1016/S0140-6736(03)15266-X
  2. 2. Fowler VGJ, Miro JM, Hoen B, Cabell CH, Abrutyn E, et al. (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293: 3012–3021. doi: 10.1001/jama.293.24.3012
  3. 3. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VGJ, et al. (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463–473. doi: 10.1001/archinternmed.2008.603
  4. 4. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, et al. (2012) Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 59: 1968–1976. doi: 10.1016/j.jacc.2012.02.029
  5. 5. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, et al. (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288: 75–81. doi: 10.1001/jama.288.1.75
  6. 6. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, et al. (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54: 1230–1239. doi: 10.1093/cid/cis199
  7. 7. Thuny F, Avierinos JF, Habib G (2010) Changing patterns in epidemiological profiles and prevention strategies in infective endocarditis: from teeth to healthcare-related infection. Eur Heart J 31: 1826–1827. doi: 10.1093/eurheartj/ehq154
  8. 8. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, et al. (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162: 90–94. doi: 10.1001/archinte.162.1.90
  9. 9. Fowler VGJ, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, et al. (2007) Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196: 738–747. doi: 10.1086/520088
  10. 10. Nienaber JJ, Sharma Kuinkel BK, Clarke-Pearson M, Lamlertthon S, Park L, et al. (2011) Methicillin-Susceptible Staphylococcus aureus Endocarditis Isolates Are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins. J Infect Dis 204: 704–713. doi: 10.1093/infdis/jir389
  11. 11. Stegger M, Lindsay JA, Moodley A, Skov R, Broens EM, et al. (2011) Rapid PCR detection of Staphylococcus aureus clonal complex 398 by targeting the restriction-modification system carrying sau1-hsdS1. J Clin Microbiol 49: 732–734. doi: 10.1128/JCM.01970-10
  12. 12. Armand-Lefevre L, Ruimy R, Andremont A (2005) Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs. Emerg Infect Dis 11: 711–714. doi: 10.3201/eid1105.040866
  13. 13. van Belkum A, Melles DC, Peeters JK, van Leeuwen WB, van Duijkeren E, et al. (2008) Methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398 in pigs and humans. Emerg Infect Dis 14: 479–483. doi: 10.3201/eid1403.070760
  14. 14. Mediavilla JR, Chen L, Uhlemann AC, Hanson BM, Rosenthal M, et al. (2012) Methicillin-Susceptible Staphylococcus aureus ST398, New York and New Jersey, USA. Emerg Infect Dis 18 ((4)) 700–702. doi: 10.3201/eid1804.111419
  15. 15. Price LB, Stegger M, Hasman H, Aziz M, Larsen J, et al. (2012) Staphylococcus aureus CC398: Host Adaptation and Emergence of Methicillin Resistance in Livestock. MBio 3 ((1)). doi: 10.1128/mbio.00305-11
  16. 16. Uhlemann AC, Porcella SF, Trivedi S, Sullivan SB, Hafer C, et al. (2012) Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. MBio 3 ((2)). doi: 10.1128/mbio.00305-11
  17. 17. Valentin-Domelier AS, Girard M, Bertrand X, Violette J, Francois P, et al. (2011) Methicillin-Susceptible ST398 Staphylococcus aureus Responsible for Bloodstream Infections: An Emerging Human-Adapted Subclone? PLoS One 6: e28369. doi: 10.1371/journal.pone.0028369
  18. 18. Rijnders MI, Deurenberg RH, Boumans ML, Hoogkamp-Korstanje JA, Beisser PS, et al. (2009) Population structure of Staphylococcus aureus strains isolated from intensive care unit patients in the netherlands over an 11-year period (1996 to 2006). J Clin Microbiol 47: 4090–4095. doi: 10.1128/JCM.00820-09
  19. 19. Monecke S, Luedicke C, Slickers P, Ehricht R (2009) Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 28: 1159–1165. doi: 10.1007/s10096-009-0752-2
  20. 20. Luedicke C, Slickers P, Ehricht R, Monecke S (2010) Molecular fingerprinting of Staphylococcus aureus from bone and joint infections. Eur J Clin Microbiol Infect Dis 29: 457–463. doi: 10.1007/s10096-010-0884-4
  21. 21. Entenza JM, Moreillon P, Senn MM, Kormanec J, Dunman PM, et al. (2005) Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect Immun 73: 990–998. doi: 10.1128/IAI.73.2.990-998.2005
  22. 22. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penades J, et al. (2002) Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 44: 1033–1044. doi: 10.1046/j.1365-2958.2002.02935.x
  23. 23. Hienz SA, Schennings T, Heimdahl A, Flock JI (1996) Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 174: 83–88. doi: 10.1093/infdis/174.1.83
  24. 24. Zhu Y, Xiong YQ, Sadykov MR, Fey PD, Lei MG, et al. (2009) Tricarboxylic acid cycle-dependent attenuation of Staphylococcus aureus in vivo virulence by selective inhibition of amino acid transport. Infect Immun 77: 4256–4264. doi: 10.1128/IAI.00195-09
  25. 25. Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, et al. (2004) Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 114: 1732–1740. doi: 10.1172/JCI23083
  26. 26. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, et al. (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 7: e1000215. doi: 10.1371/journal.pmed.1000215
  27. 27. Chang FY, MacDonald BB, Peacock JEJ, Musher DM, Triplett P, et al. (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82: 322–332. doi: 10.1097/
  28. 28. Kaasch AJ, Fowler VGJ, Rieg S, Peyerl-Hoffmann G, Birkholz H, et al. (2011) Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis 53: 1–9. doi: 10.1093/cid/cir320
  29. 29. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VGJ, et al. (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633–638. doi: 10.1086/313753
  30. 30. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, et al. (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41: 5442–5448. doi: 10.1128/JCM.41.12.5442-5448.2003
  31. 31. Mellmann A, Weniger T, Berssenbrugge C, Rothganger J, Sammeth M, et al. (2007) Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiol 7: 98. doi: 10.1186/1471-2180-7-98